FIELD: chemistry.
SUBSTANCE: present invention relates to organic chemistry and specifically to a radio-protective pharmacological agent characterized by the fact that it contains 1-isobutanoyl-2-isopropylisothiourea phosphate as an active substance with structural formula
.
EFFECT: disclosed is a novel organic compound which has an effective and stable radioprotective action, as well as broader possibilities for developing effective and safe anti-radiation agents, and agents for preventing complications of radiation therapy.
7 cl, 3 tbl, 4 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
IMPROVED METHOD FOR OBTAINING RADIOPROTECTIVE AGENT 1-ISOBUTANOYL-2-ISOPROPYLISOTHIOUREA HYDROBROMIDE | 2023 |
|
RU2806650C1 |
METHOD OF PHARMACOLOGICAL PROTECTION FROM IONIZING RADIATION | 2017 |
|
RU2663465C1 |
VASOCONSTRICTOR | 2011 |
|
RU2475479C1 |
AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
COMPLEX ANTI-TUMORAL PRODUCT | 2020 |
|
RU2751776C2 |
METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
METHOD FOR PREVENTING AND TREATING ACUTE RADIATION INJURY | 2019 |
|
RU2694222C2 |
AGENT FOR PREVENTION OF ACUTE RADIATION DISEASE | 2015 |
|
RU2599844C1 |
PREPARATION FOR TREATING ACUTE RADIATION LESIONS | 2004 |
|
RU2260425C1 |
AGENT FOR EARLY THERAPY OF RADIATION DAMAGES | 1998 |
|
RU2164139C2 |
Authors
Dates
2020-10-07—Published
2020-04-15—Filed